 |
Colon Cancer
A worldwide, unmet need exists for effective serum and tissue tests to detect colon cancer early.
Colon Cancer Facts:
- Colon cancer is the third most common cancer found in men and women in the US
- 95% of colon and rectal cancers are cancers of the cells that line the inside of the colon and rectum (adenocarcinomas)
- Most of these cancers begin as a polyp or growth of tissue (also known as adenomas); removing polyps early may prevent the cancer within from becoming widespread and life-threatening
- Colon cancer most often metastasizes (migrates) from the colon to the liver
- Early detection of colon cancer significantly affects patient outcomes
Our Technologies
ColoMark® Serum Assay
- Company developed technology
- Multiple fully sequenced proteins show differential protein expression in normal vs. cancerous colon tissue
- Evaluating a panel of markers
- US provisional patent application filed for colon cancer diagnostic
Market Size
Colon Cancer Screening
- The US population aged 50-79 is approximately 76 million
- 15 million FOB tests are run in the US each year
- 17 million colonoscopies are performed in the US each year
- Approximately 147,000 new cases are diagnosed in the US per year
|
|
|
|
|
